Lupin Limited has informed the Exchange about press release dated 26-Aug-2022 titled Lupin Announces UK MHRA Approval of Lutio�� (Tiotropium bromide inhalation powder) for Treatment of COPD…….
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
